AU Stock MarketDetailed Quotes
ARX Aroa Biosurgery Ltd
- 0.570
- -0.030-5.00%
20min DelayMarket Closed Nov 4 16:00 AET
196.59MMarket Cap-20357P/E (Static)
0.610High0.570Low68.25KVolume0.590Open0.600Pre Close41.21KTurnover0.87052wk High0.03%Turnover Ratio344.90MShares0.44052wk Low-0.028EPS TTM147.90MFloat Cap1.745Historical HighLossP/E (Static)259.47MShs Float0.440Historical Low-0.028EPS LYR6.67%Amplitude--Dividend TTM2.25P/B1Lot Size--Div YieldTTM
Aroa Biosurgery Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Mar 30, 2024 | (FY)Mar 30, 2023 | (FY)Mar 30, 2022 | (FY)Mar 30, 2021 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | 17.81%62.39M | 83.62%52.96M | 33.14%28.84M | 21.66M |
| Revenue from customers | 22.01%59.85M | 79.67%49.06M | 41.33%27.3M | --19.32M |
| Other cash income from operating activities | -35.02%2.53M | 153.73%3.9M | -34.38%1.54M | --2.34M |
| Cash paid | -23.53%-70.48M | -48.53%-57.06M | -48.83%-38.41M | -25.81M |
| Payments to suppliers for goods and services | -23.53%-70.48M | -48.53%-57.06M | -48.83%-38.41M | ---25.81M |
| Direct dividend received | --917.347 | ---- | ---- | ---- |
| Direct interest paid | ---9.17K | ---- | -59.05%-1.25M | ---783.07K |
| Direct interest received | 44.57%1.58M | 766.41%1.1M | 2.76%126.41K | --123.01K |
| Direct tax refund paid | 52.99%-248.6K | -2,894.84%-528.88K | -108.33%-17.66K | --212.06K |
| Operating cash flow | -91.61%-6.77M | 67.03%-3.53M | -132.98%-10.71M | ---4.6M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 37.09%9.31M | 120.95%6.79M | -64.21%-32.41M | -19.74M |
| Capital expenditure reported | -107.33%-2.59M | ---1.25M | ---- | ---- |
| Net PPE purchase and sale | 42.73%-3.23M | -36.29%-5.64M | -256.56%-4.14M | ---1.16M |
| Net intangibles purchas and sale | -152.45%-590.77K | 39.48%-234.02K | -79.23%-386.65K | ---215.73K |
| Net investment purchase and sale | 12.95%15.72M | 149.91%13.92M | -51.87%-27.88M | ---18.36M |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 37.09%9.31M | 120.95%6.79M | -64.21%-32.41M | ---19.74M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -101.06%-948.54K | -101.35%-471.78K | 2.70%34.98M | 34.06M |
| Net issuance payments of debt | ---- | ---- | -233.64%-8.84M | --6.62M |
| Net common stock issuance | -101.06%-948.54K | -101.06%-471.78K | 59.07%44.72M | --28.11M |
| Net other financing activities | ---- | ---- | -33.38%-895.06K | ---671.07K |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -101.06%-948.54K | -101.35%-471.78K | 2.70%34.98M | --34.06M |
| Net cash flow | ||||
| Beginning cash position | 51.65%8.75M | -59.63%5.77M | 304.48%14.3M | --3.53M |
| Current changes in cash | -42.76%1.6M | 134.25%2.79M | -183.73%-8.14M | --9.72M |
| Effect of exchange rate changes | -40.11%222K | 187.46%370.68K | -149.17%-423.83K | --862.02K |
| End cash Position | 18.36%10.57M | 55.85%8.93M | -59.42%5.73M | --14.12M |
| Free cash from | -23.63%-13.17M | 30.07%-10.66M | -155.07%-15.24M | ---5.97M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data